TCTR20221112001招募中3 期
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.
The National Science Research and Innovation Fund0 个研究点目标入组 340 人开始时间: 2022年11月12日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 340
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •20 years old or older who never had prior clinical symptoms of SARS-CoV-2 infection.
排除标准
- •immunocompromised persons, receiving immunosuppressive drugs, receiving blood products and pregnancy
研究者
相似试验
进行中（未招募）
1 期
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2013/2014 SeasoEUCTR2013-000881-12-BEAbbott Biologicals B.V130
进行中（未招募）
不适用
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 SeasoEUCTR2012-001032-57-DEAbbott Biologicals B.V.130
进行中（未招募）
不适用
Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects = 18 and = 60 Years and Elderly Subjects = 61 Years of Age - Influvac Annual Update 2008/2009EUCTR2008-001038-28-BESolvay Biologicals BV120
进行中（未招募）
不适用
Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects = 18 and = 60 Years and Elderly Subjects = 61 Years of Age - Influvac Annual Update 2008/2009EUCTR2008-001038-28-DESolvay Biologicals BV120
进行中（未招募）
不适用
Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2010/2011. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects =18 and =60 Years and Elderly Subjects = 61 Years of Age. - Influvac Annual Update 2010/2011Prophylaxis of InfluenzaMedDRA version: 12.1Level: HLTClassification code 10022005Term: Influenza viral infectionsEUCTR2010-018350-13-BEAbbott Biologicals B.V.120